10-53866641-C-A
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_033056.4(PCDH15):c.3717+1G>T variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,612,328 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_033056.4 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCDH15 | NM_001384140.1 | c.3717+1G>T | splice_donor_variant | ENST00000644397.2 | NP_001371069.1 | |||
PCDH15 | NM_033056.4 | c.3717+1G>T | splice_donor_variant | ENST00000320301.11 | NP_149045.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDH15 | ENST00000320301.11 | c.3717+1G>T | splice_donor_variant | 1 | NM_033056.4 | ENSP00000322604 | ||||
PCDH15 | ENST00000644397.2 | c.3717+1G>T | splice_donor_variant | NM_001384140.1 | ENSP00000495195 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151986Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250906Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135636
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1460342Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 726566
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151986Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74248
ClinVar
Submissions by phenotype
Usher syndrome type 1F Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 06, 2023 | Variant summary: PCDH15 c.3717+1G>T is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes the canonical 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 4e-06 in 250906 control chromosomes (gnomAD). c.3717+1G>T has been reported in the literature in multiple individuals affected with Usher Syndrome Type 1F and the variant segregated with the disease (example: Ahmed_2018). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Jan 24, 2023 | The c.3717+1G>T variant in PCDH15 has been reported in 1 individual, in the homozygous state, with Usher syndrome type 1F (PMID: 18719945), segregated with disease in 5 affected relatives from 1 family (PMID: 18719945), and has been identified in 0.002% (2/128820) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs748706627). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID#: 1073476) and has been interpreted as pathogenic or likely pathogenic by Invitae and Myriad Women's Health, Inc.. This variant is located in the 3' splice region. Computational tools predict use of a cryptic splice site that includes translation of a premature termination codon, though this information is not predictive enough to determine pathogenicity. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Usher syndrome type 1F. ACMG/AMP Criteria applied: PP1_strong, PVS1, PM2_supporting, PM3_supporting (Richards 2015). - |
Autosomal recessive nonsyndromic hearing loss 23 Pathogenic:1
Pathogenic, flagged submission | clinical testing | Baylor Genetics | Aug 18, 2023 | - - |
Usher syndrome type 1D Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Nov 16, 2021 | NM_033056.3(PCDH15):c.3717+1G>T is a canonical splice variant classified as likely pathogenic in the context of PCDH15-related disorders. c.3717+1G>T has been observed in cases with relevant disease (PMID: 18719945). Functional assessments of this variant are not available in the literature. c.3717+1G>T has been observed in population frequency databases (gnomAD: NFE 0.002%). In summary, NM_033056.3(PCDH15):c.3717+1G>T is a canonical splice variant that has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 23, 2023 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 1073476). Disruption of this splice site has been observed in individual(s) with hearing impairment (PMID: 18719945). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs748706627, gnomAD 0.002%). This sequence change affects a donor splice site in intron 27 of the PCDH15 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PCDH15 are known to be pathogenic (PMID: 11398101, 11487575, 14570705). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at